President and CEO of $EXPO sells 1,670 shares in insider sale.

The recent sale of 1,670 shares of $EXPO by Catherine Corrigan, the company’s President and CEO, has caught the attention of investors. The transaction, detailed in an SEC filing, netted an estimated $119,207 for Corrigan. This sale represented approximately 2.0% of her total holdings of that class of stock, leaving her with 82,052 shares moving forward.

Insider trading activity within $EXPO has been active in the past six months, with a total of eight transactions taking place. Notably, all insider trades have been sales, with no purchases recorded. Besides Catherine Corrigan’s recent sale, other key executives, including Bradley A. James, John Pye, Richard Reiss, Joseph Rakow, and Joseph Sala, have also sold shares, contributing to the overall insider trading picture for the company.

Looking at institutional investor activity, significant moves have been made in $EXPO stock. In the second quarter of 2025, 182 institutional investors have added shares to their portfolios, while 223 have decreased their positions. Notable additions include Royal Bank of Canada, First Trust Advisors LP, and Morgan Stanley, with substantial share increases in their holdings of $EXPO stock. Conversely, Neuberger Berman Group LLC and Cubist Systematic Strategies, LLC have reduced their positions in the company.

In addition to insider and institutional investor activity, members of Congress have also been involved in trading $EXPO stock. In the past six months, Congressional members have executed three transactions, two of which were purchases and one a sale. Representative Jefferson Shreve stands out as a frequent trader of $EXPO stock, conducting three trades during the period.

Investors interested in monitoring insider transactions, hedge fund activity, and Congressional trading of $EXPO stock can access detailed information through Quiver Quantitative’s specialized dashboards. It is essential to note that this article is intended to provide information and should not be construed as financial advice. Readers are encouraged to review Quiver Quantitative’s disclaimers for a full understanding of the content presented.